IQVIA Holdings' Shares Down After Outlook for Adjusted Earnings Misses

Dow Jones
02/06

By Amira McKee

 

Shares of IQVIA Holdings retreated after the biotech company's adjusted earnings outlook for missed Wall Street's expectations.

The stock fell 9% to $185.16 in Thursday morning trading. The shares have declined 9.6% in the past year.

IQVIA expects adjusted earnings per share of $12.55 to $12.85, on revenue of $17.15 billion to $17.35 billion for the 2026 fiscal year.

Analysts polled by FactSet are looking for adjusted earnings of $12.93 per share, and revenue of $17.07 billion in 2026.

The guidance includes a step up in interest expense of approximately $80 million from annualization of financing activities completed in 2025 and expected refinancing to be completed in 2026.

The Durham, N.C., company logged fourth-quarter net income of $514 million, or $2.99 a share, compared with earnings of $437 million, or $2.42 a share, in the same period a year earlier.

Fourth-quarter revenue increased 10.3% to $4.36 billion, beating Wall Street's forecast of $4.24 billion.

 

Write to Amira McKee at amira.mckee@wsj.com

 

(END) Dow Jones Newswires

February 05, 2026 11:59 ET (16:59 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10